These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20844543)

  • 1. Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine.
    Hayashi K; Saruta T; Goto Y; Ishii M;
    Hypertens Res; 2010 Nov; 33(11):1211-20. PubMed ID: 20844543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of strict- and mild-blood pressure control in elderly hypertensive patients: a per-protocol analysis of JATOS.
    Rakugi H; Ogihara T; Goto Y; Ishii M;
    Hypertens Res; 2010 Nov; 33(11):1124-8. PubMed ID: 20686490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).
    JATOS Study Group
    Hypertens Res; 2008 Dec; 31(12):2115-27. PubMed ID: 19139601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efonidipine improves renal function and decreases proteinuria in elderly hypertensive patients in the JATOS study.
    Okura T
    Hypertens Res; 2010 Nov; 33(11):1112-3. PubMed ID: 20811385
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of antihypertensive treatment on cardiovascular events in elderly hypertensive patients: Japan's Benidipine Research on Antihypertensive Effects in the Elderly (J-BRAVE).
    Saito I; Suzuki H; Kageyama S; Saruta T
    Clin Exp Hypertens; 2011; 33(2):133-40. PubMed ID: 21269056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease.
    Okada T; Nakao T; Matsumoto H; Nagaoka Y; Tomaru R; Iwasawa H; Wada T
    Hypertens Res; 2009 Dec; 32(12):1123-9. PubMed ID: 19816503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial.
    Ogihara T; Saruta T; Rakugi H; Fujimoto A; Ueshima K; Yasuno S; Oba K; Takeda K; Higaki J; Nakao K;
    Hypertens Res; 2009 Apr; 32(4):248-54. PubMed ID: 19347033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
    Ishimitsu T; Kameda T; Akashiba A; Takahashi T; Ohta S; Yoshii M; Minami J; Ono H; Numabe A; Matsuoka H
    Hypertens Res; 2007 Jul; 30(7):621-6. PubMed ID: 17785930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial.
    Jardine MJ; Ninomiya T; Perkovic V; Cass A; Turnbull F; Gallagher MP; Zoungas S; Lambers Heerspink HJ; Chalmers J; Zanchetti A
    J Am Coll Cardiol; 2010 Sep; 56(12):956-65. PubMed ID: 20828648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypertension in patients 85 years of age or older: a J-BRAVE substudy.
    Saito I; Suzuki H; Kageyama S; Saruta T
    Clin Exp Hypertens; 2011; 33(5):275-80. PubMed ID: 21787236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of efonidipine and ACE inhibitors on proteinuria in human hypertension with renal impairment.
    Hayashi K; Kumagai H; Saruta T
    Am J Hypertens; 2003 Feb; 16(2):116-22. PubMed ID: 12559677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D; Moritz ML; Vats A; Janosky JE
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulse pressure and progression of chronic kidney disease.
    Arulkumaran N; Diwakar R; Tahir Z; Mohamed M; Kaski JC; Banerjee D
    J Nephrol; 2010; 23(2):189-93. PubMed ID: 20119928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year results of an open-label study on antiproteinuric effect of benidipine in elderly patients with chronic kidney disease.
    Tomino Y; Shimizu Y; Hamada C; Kurusu A; Ohsawa I; Suzuki Y; Tsuge T; Io H; Kobayashi N; Takeda Y; Asanuma K; Tanaka Y; Suzuki H; Nakata J; Takara K; Horikoshi S
    J Nephrol; 2011; 24(6):756-63. PubMed ID: 21360472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of blood pressure control and metabolic syndrome with cardiovascular risk in elderly Japanese: JATOS study.
    Kawano Y; Ogihara T; Saruta T; Goto Y; Ishii M
    Am J Hypertens; 2011 Nov; 24(11):1250-6. PubMed ID: 21814293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.